CROI 2017 Program and Information

Program and Agenda

399 CEREBRAL ENDOTHELIAL FUNCTION CORRELATESWITH PERFORMANCE ON COGNITIVE SCREENING TEST Natasha Mehta 1 , Yanling Li 2 , Yinghuan Hu 2 , Huanling Wang 2 , Weihai Xu 2 , Taisheng Li 2 , Felicia C Chow 1 1 Univ of California San Francisco, San Francisco, CA, USA, 2 Peking Union Med Coll Hosp, Beijing, China 400 RANDOMIZED TRIAL OF BRAIN FUNCTION CHANGE AFTER STARTING TDF/FTC+ATV/R OR ABC/3TC+EFV Ignacio Pérez-Valero 1 , Alicia Gonzalez-Baeza 1 , Lucia Bailon 1 , Belén Alejos 2 , Rocio Montejano 1 , Victor Hontanon 1 , Helena Melero 3 , Marisa Montes 1 , Carmen Bayon 1 , Jose R. Arribas 1 1 Hosp Univ La Paz, Madrid, Spain, Spain, 2 Instituto de Salud Carlos III, Madrid, Spain, 3 Univ Rey Juan Carlos, Alcorcón, Spain 401 RESTING CEREBRAL BLOOD FLOWAND RISKY DECISION-MAKING INHIV+AND HIV– YOUNG ADULTS Robert S. Smith 1 , Anika Guha 2 , Aaron Tanenbaum 1 , Florin Vaida 3 , Robert Paul 4 , Beau M. Ances 1 1 Washington Univ in Saint Louis, Saint Louis, MO, USA, 2 Univ of California Los Angeles, Los Angeles, CA, USA, 3 Univ of California San Diego, San Diego, USA, 4 Univ of Missouri–St. Louis, St. Louis, MO, USA 402 MRI REVEALS ENLARGED INTRACRANIAL ARTERIES INHIV- ASSOCIATED NEUROCOGNITIVE DISORDER Govind Nair, Angela Summers, Joseph Snow, Daniel S. Reich, Sally Steinbach, Paba M. DeAlwis, Bryan Smith, Avindra Nath NIH, Bethesda, MD, USA 403 WORKINGMEMORY INHIV+YOUNG ADULTS: FUNCTIONAL IMAGING USINGMAGNETOENCEPHALOGRAPHY Sharon Nichols 1 , Ashley R. Swan 2 , Annemarie A. Quinto 2 , Chris Fennema- Notestine 2 , Mingxiong Huang 2 1 Univ of California San Diego, La Jolla, CA, USA, 2 Univ of California San Diego, San Diego, CA, USA Poster P-G2 DRUG-DRUG INTERACTIONS Poster Hall - 4 EF 2:30 PM - 4:00 PM 409 COBICISTAT, BUT NOT RITONAVIR, INCREASES DABIGATRAN EXPOSURE Kristina M. Brooks 1 , Lori A. Gordon 2 , Scott Penzak 3 , Anela Kellogg 4 , Maryellen McManus 1 , Khanh Nghiem 1 , Jay Lozier 1 , Jomy M. George 1 , Colleen Hadigan 5 , Parag Kumar 1 1 NIH, Bethesda, MD, USA, 2 Xavier Univ of Louisiana, New Orleans, LA, USA, 3 Univ of North Texas, Fort Worth, TX, USA, 4 Leidos Biomed Rsr, Inc, Bethesda, MD, USA, 5 NIAID, Bethesda, MD, USA 409a EARLY TERMINATION OF A PK STUDY BETWEEN DOLUTEGRAVIR ANDWEEKLY ISONIAZID/RIFAPENTINE

Poster Sessions • Wednesday

Kristina M. Brooks 1 , Alice K. Pau 2 , Jomy M. George 1 , Raul Alfaro 1 , Anela Kellogg 3 , Mary McLaughlin 2 , Maryellen McManus 1 , Colleen Hadigan 2 , Joseph A. Kovacs 1 , Parag Kumar 1 1 NIH Clinical Center, Bethesda, MD, USA, 2 NIAID, NIH, Bethesda, MD, USA, 3 Leidos Biomedical Research, Inc, Bethesda, MD, USA

CROI 2017 133